Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Florman

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
Hepatology (Baltimore, Md.)|March 4, 2020
Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan CriteriaAni Kardashian, Sander S Florman, Brandy Haydel, et al.
Clinical Transplantation|December 22, 2020
Healthcare resource use among solid organ transplant recipients hospitalized with COVID-19Madeleine R Heldman, Olivia S Kates, Brandy M Haydel, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 11, 2020
Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma FactorsNia Adeniji, Vinodhini Arjunan, Vijay Prabhakar, et al.
JCI Insight|March 12, 2026
Human antibody repertoire among kidney donors with and without HIVXianming Zhu, William R Morgenlander, Diane M Brown, et al.
Annals of Surgery|March 15, 2019
Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant ConsortiumJoseph DiNorcia, Sander S Florman, Brandy Haydel, et al.
Annals of Surgery|June 28, 2017
Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant ConsortiumVatche G Agopian, Michael P Harlander-Locke, Richard M Ruiz, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 7, 2023
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant ConsortiumBenjamin V Tran, Dimitrios Moris, Daniela Markovic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2021
National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United StatesWilliam A Werbel, Diane M Brown, Oyinkansola T Kusemiju, et al.
BMJ Open|June 12, 2024
Incidence, management and outcomes in hepatic artery complications after paediatric liver transplantation: protocol of the retrospective, international, multicentre HEPATIC RegistryWeihao Li, Hubert P J van der Doef, Barbara E Wildhaber, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Hepatology (Baltimore, Md.)|March 4, 2020
Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan CriteriaAni Kardashian, Sander S Florman, Brandy Haydel, et al.
Clinical Transplantation|December 22, 2020
Healthcare resource use among solid organ transplant recipients hospitalized with COVID-19Madeleine R Heldman, Olivia S Kates, Brandy M Haydel, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 11, 2020
Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma FactorsNia Adeniji, Vinodhini Arjunan, Vijay Prabhakar, et al.
JCI Insight|March 12, 2026
Human antibody repertoire among kidney donors with and without HIVXianming Zhu, William R Morgenlander, Diane M Brown, et al.
Annals of Surgery|March 15, 2019
Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant ConsortiumJoseph DiNorcia, Sander S Florman, Brandy Haydel, et al.
Annals of Surgery|June 28, 2017
Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant ConsortiumVatche G Agopian, Michael P Harlander-Locke, Richard M Ruiz, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 7, 2023
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant ConsortiumBenjamin V Tran, Dimitrios Moris, Daniela Markovic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2021
National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United StatesWilliam A Werbel, Diane M Brown, Oyinkansola T Kusemiju, et al.
BMJ Open|June 12, 2024
Incidence, management and outcomes in hepatic artery complications after paediatric liver transplantation: protocol of the retrospective, international, multicentre HEPATIC RegistryWeihao Li, Hubert P J van der Doef, Barbara E Wildhaber, et al.
Pageof 12